This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tilt Biotherapeutics Oy. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Suvi Parviainen: Innovator in Cancer Therapies
Introduction
Suvi Parviainen is a notable inventor based in Helsinki, Finland. He has made significant contributions to the fields of life sciences and medicine, particularly in cancer therapies. His innovative work focuses on developing advanced therapeutic methods to combat cancer in humans.
Latest Patents
Suvi Parviainen holds a patent for "Oncolytic adenoviruses coding for bi-specific antibodies." This invention relates to an oncolytic adenoviral vector that encodes a bispecific monoclonal antibody. The patent outlines methods and uses of these vectors, which can be utilized in conjunction with adoptive cell therapies to enhance cancer treatment.
Career Highlights
Suvi Parviainen is associated with Tilt Biotherapeutics Oy, a company dedicated to advancing biotherapeutic solutions. His work at the company emphasizes the importance of innovative approaches in the fight against cancer. With a focus on developing effective therapies, he has positioned himself as a key player in the biotechnology sector.
Collaborations
Suvi collaborates with esteemed colleagues, including Akseli Hemminki and Siri Tähtinen. Their combined expertise contributes to the advancement of cancer therapies and the development of groundbreaking treatments.
Conclusion
Suvi Parviainen's contributions to cancer therapies through his innovative patent and work at Tilt Biotherapeutics Oy highlight the importance of research and collaboration in the medical field. His dedication to improving human health through scientific advancements is commendable.